Wasting and Cachexia in Patients with HIV
- 1 August 1997
- journal article
- review article
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 11 (4), 259-267
- https://doi.org/10.1089/apc.1997.11.259
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infectionAIDS, 1996
- Effects of Dietary n-3 Fatty Acid Supplementation in Men with Weight Loss Associated with the Acquired Immune Deficiency Syndrome: Relation to Indices of Cytokine ProductionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Taste and smell losses in HIV infected patientsPhysiology & Behavior, 1995
- Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDSJournal of Pain and Symptom Management, 1995
- Testosterone replacement therapy in HIV illnessGeneral Hospital Psychiatry, 1995
- Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndromeJournal of Clinical Endocrinology & Metabolism, 1994
- Clinical risk factors for malnutrition in HIV-1-infected patientsAIDS, 1993
- Effects of Enteric Parasitoses and HIV Infection upon Small Intestinal Structure and Function in Patients with AIDSJournal of Clinical Gastroenterology, 1993
- A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancerCancer, 1990
- NUTRITION, IMMUNITY, AND INFECTION: PRESENT KNOWLEDGE AND FUTURE DIRECTIONSThe Lancet, 1983